May 18, 2021
CohBar Reports First Quarter 2021 Financial Results and Provides Business Update
Company to host conference call at 5:00 p.m. ETMENLO PARK, Calif., May 17, 2021 (GLOBE NEWSWIRE) — CohBar, Inc. (NASDAQ:…
Pharmaceuticals, Biotechnology and Life Sciences
Company to host conference call at 5:00 p.m. ETMENLO PARK, Calif., May 17, 2021 (GLOBE NEWSWIRE) — CohBar, Inc. (NASDAQ:…
Rolling NDA submission for CUTX-101 for the treatment of Menkes disease is expected to begin in the second half of…
Post hoc analyses by estimated on-treatment serum EPA levels in the VASCEPA group suggest potentially reduced incidence of new heart…
PORTLAND, Ore., May 14, 2021 (GLOBE NEWSWIRE) — Golden Leaf Holdings Ltd. (CSE:GLH) (OTCQB:GLDFF) (“Golden Leaf” or the “Company”), operating…
EMPAVELI, the first targeted C3 therapy, is approved for use in adults with PNH who are: Treatment naïveSwitching from C5…
PALO ALTO, Calif., May 14, 2021 (GLOBE NEWSWIRE) — BridgeBio Pharma, Inc. (Nasdaq: BBIO), a clinical-stage biopharmaceutical company focused on…
SAN DIEGO, May 14, 2021 (GLOBE NEWSWIRE) — Prometheus Biosciences, Inc. (Nasdaq: RXDX), a clinical-stage biotechnology company pioneering a precision…
WORCESTER, Mass., May 14, 2021 (GLOBE NEWSWIRE) — Mustang Bio, Inc. (“Mustang”) (NASDAQ: MBIO), a clinical-stage biopharmaceutical company focused on…
TORONTO, May 14, 2021 (GLOBE NEWSWIRE) — Aleafia Health Inc. (TSX: AH, OTCQX: ALEAF) (“Aleafia Health” or the “Company”) a…
VANCOUVER, British Columbia, May 14, 2021 (GLOBE NEWSWIRE) — TOWER ONE WIRELESS CORP. (CSE: TO) (OTCQB: TOWTF) (Frankfurt: 1P3N) (“Tower…